ARTIDIS

ARTIDIS rapidly diagnoses cancer, detects its aggressiveness and predicts the probability of a patient developing metastases based on the nanomechanical biomarker for cancer. The ARTIDISNET platform combines the nanomechanical biomarker with the patient’s clinical data to guide the best therapy choice for each individual patient.
While waiting for a diagnosis over several days, patients have to deal with high anxiety and a challenging emotional experience. Healthcare professionals are dedicated to cure their patients but are challenged by the lack of automated and accurate tools supporting their decision-making. ARTIDIS provides a data-based diagnosis in less than three hours.